newsfilter
← Latest News
GlobeNewswire·

CymaBay Therapeutics to Present at Upcoming Investment Conferences

NEWARK, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today